October Issue: Conversion to Resection After Neoadjuvant #Gemcitabine , #Cisplatin , and #NabPaclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis

https://rdcu.be/eMq0E

Rachna T. Shroff: SWOG S1815 shows no OS benefit for nab-paclitaxel in BTCs - OncoDaily Rachna T. Shroff: SWOG S1815 shows no OS benefit for nab-paclitaxel in BTCs / advanced biliary cancer, Ben Westphalen, Biliary tract cancers, BTC research,

SWOG S1815 shows no OS benefit for nab-paclitaxel in BTCs - Rachna T. Shroff
@rachnatshroff.bsky.social

oncodaily.com/science/rach...

#AdvancedBiliaryCancer #BTCResearch #Cancer #Medicine #GemcitabineCisplatin #JCO #ASCO #NabPaclitaxel #Health #OncoDaily #Oncology #SWOG #S1815